CoreWeave’s $9 billion all-stock deal to buy crypto miner Core Scientific has been rejected by shareholders, marking the second failed takeover attempt. CoreWeave’s stock dropped almost 6.3% on the news. The company’s Q2 2025 results showed a 207% year-over-year revenue increase to $1.2 billion, with a backlog of $30.1 billion. Despite the rejection, analysts maintain a “Moderate Buy” consensus on CoreWeave stock, with a price target of $141.84 suggesting a potential 41% upside. Investors await the company’s fiscal Q3 earnings report on Nov. 10 to gauge future profitability.

Read more at Barchart: Core Scientific Just Rejected CoreWeave’s Bid. Should You Buy CRWV Stock Here or Stay Far Away?